Multicenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane-Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa

Ceftolozane-tazobactam (C/T) is a novel beta-lactam–beta-lactamase inhibitor combination antibiotic approved by the U.S. Food and Drug Administration in 2014 for the treatment of complicated intra-abdominal infections (in combination with metronidazole) and complicated urinary tract infections. In t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Microbiol
Auteurs principaux: Bailey, Adam L., Armstrong, Tom, Dwivedi, Hari-Prakash, Denys, Gerald A., Hindler, Janet, Campeau, Shelley, Traczewski, Maria, Humphries, Romney, Burnham, Carey-Ann D.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2018
Sujets:
Bacteriology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6113460/
https://ncbi.nlm.nih.gov/pubmed/29976590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00717-18
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires